Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Revenues
Total Revenues, net	$ 55,209	$ 57,199
Cost of goods sold
Cost of goods sold	44,293	43,165
Gross profit	10,916	14,034
Operating expenses
Research and development	1,805	1,063
Selling, General and Administrative	15,802	13,682
Depreciation	178	151
Intangible amortization	2,114	2,002
Total operating expenses	19,899	16,898
Loss from operations	(8,983)	(2,864)
Other income (expenses):
Interest expense	(2,628)	(2,555)
Other (expenses) income	112	(23)
Total other expense	(2,516)	(2,578)
Net loss before income taxes	(11,499)	(5,442)
(Provision) benefit for Income Taxes
Current	(5)	(14)
Deferred
Total income tax benefit (provision)	(5)	(14)
Net loss from continuing operations	(11,504)	(5,456)
Less: Preferred stock - series C dividend	(191)	(146)
Net loss attributable to the common stockholders	(11,313)	(5,310)
Foreign currency translation adjustment	(167)
Other comprehensive income (loss)	$ (11,150)	$ (5,310)
Net loss per share - basic	$ (2.46)	$ (1.37)
Net loss per share - diluted	$ (2.66)	$ (1.37)
Weighted average number of common shares outstanding - basic and diluted	4,322,303	3,889,478